A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1

Standard

A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1. / Luley, Kim B; Biedermann, Shauni B; Künstner, Axel; Busch, Hauke; Franzenburg, Sören; Schrader, Jörg; Grabowski, Patricia; Wellner, Ulrich F; Keck, Tobias; Brabant, Georg; Schmid, Sebastian M; Lehnert, Hendrik; Ungefroren, Hendrik.

In: CANCERS, Vol. 12, No. 3, 14.03.2020, p. 691.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Luley, KB, Biedermann, SB, Künstner, A, Busch, H, Franzenburg, S, Schrader, J, Grabowski, P, Wellner, UF, Keck, T, Brabant, G, Schmid, SM, Lehnert, H & Ungefroren, H 2020, 'A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1', CANCERS, vol. 12, no. 3, pp. 691. https://doi.org/10.3390/cancers12030691

APA

Luley, K. B., Biedermann, S. B., Künstner, A., Busch, H., Franzenburg, S., Schrader, J., Grabowski, P., Wellner, U. F., Keck, T., Brabant, G., Schmid, S. M., Lehnert, H., & Ungefroren, H. (2020). A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1. CANCERS, 12(3), 691. https://doi.org/10.3390/cancers12030691

Vancouver

Luley KB, Biedermann SB, Künstner A, Busch H, Franzenburg S, Schrader J et al. A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1. CANCERS. 2020 Mar 14;12(3):691. https://doi.org/10.3390/cancers12030691

Bibtex

@article{506b0b2b582244fbb846bf1bd707f4e9,
title = "A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1",
abstract = "Experimental models of neuroendocrine tumor disease are scarce, with only a few existing neuroendocrine tumor cell lines of pancreatic origin (panNET). Their molecular characterization has so far focused on the neuroendocrine phenotype and cancer-related mutations, while a transcription-based assessment of their developmental origin and malignant potential is lacking. In this study, we performed immunoblotting and qPCR analysis of neuroendocrine, epithelial, developmental endocrine-related genes as well as next-generation sequencing (NGS) analysis of microRNAs (miRs) on three panNET cell lines, BON-1, QGP-1, and NT-3. All three lines displayed a neuroendocrine and epithelial phenotype; however, while insulinoma-derived NT-3 cells preferentially expressed markers of mature functional pancreatic β-cells (i.e., INS, MAFA), both BON-1 and QGP-1 displayed high expression of genes associated with immature or non-functional β/δ-cells genes (i.e., NEUROG3), or pancreatic endocrine progenitors (i.e., FOXA2). NGS-based identification of miRs in BON-1 and QGP-1 cells revealed the presence of all six members of the miR-17-92 cluster, which have been implicated in b-cell function and differentiation, but also have roles in cancer being both oncogenic or tumor suppressive. Notably, both BON-1 and QGP-1 cells expressed several miRs known to be negatively associated with epithelial-mesenchymal transition, invasion or metastasis. Moreover, both cell lines failed to exhibit migratory activity in vitro. Taken together, NT-3 cells resemble mature functional β-cells, while both BON-1 and QGP-1 are more similar to immature/non-functional pancreatic β/δ-cells or pancreatic endocrine progenitors. Based on the recent identification of three transcriptional subtypes in panNETs, NT-3 cells resemble the {"}islet/insulinoma tumors{"} (IT) subtype, while BON-1 and QGP-1 cells were tentatively classified as {"}metastasis-like/primary{"} (MLP). Our results provide a comprehensive characterization of three panNET cell lines and demonstrate their relevance as neuroendocrine tumor models.",
author = "Luley, {Kim B} and Biedermann, {Shauni B} and Axel K{\"u}nstner and Hauke Busch and S{\"o}ren Franzenburg and J{\"o}rg Schrader and Patricia Grabowski and Wellner, {Ulrich F} and Tobias Keck and Georg Brabant and Schmid, {Sebastian M} and Hendrik Lehnert and Hendrik Ungefroren",
year = "2020",
month = mar,
day = "14",
doi = "10.3390/cancers12030691",
language = "English",
volume = "12",
pages = "691",
journal = "CANCERS",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "3",

}

RIS

TY - JOUR

T1 - A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1

AU - Luley, Kim B

AU - Biedermann, Shauni B

AU - Künstner, Axel

AU - Busch, Hauke

AU - Franzenburg, Sören

AU - Schrader, Jörg

AU - Grabowski, Patricia

AU - Wellner, Ulrich F

AU - Keck, Tobias

AU - Brabant, Georg

AU - Schmid, Sebastian M

AU - Lehnert, Hendrik

AU - Ungefroren, Hendrik

PY - 2020/3/14

Y1 - 2020/3/14

N2 - Experimental models of neuroendocrine tumor disease are scarce, with only a few existing neuroendocrine tumor cell lines of pancreatic origin (panNET). Their molecular characterization has so far focused on the neuroendocrine phenotype and cancer-related mutations, while a transcription-based assessment of their developmental origin and malignant potential is lacking. In this study, we performed immunoblotting and qPCR analysis of neuroendocrine, epithelial, developmental endocrine-related genes as well as next-generation sequencing (NGS) analysis of microRNAs (miRs) on three panNET cell lines, BON-1, QGP-1, and NT-3. All three lines displayed a neuroendocrine and epithelial phenotype; however, while insulinoma-derived NT-3 cells preferentially expressed markers of mature functional pancreatic β-cells (i.e., INS, MAFA), both BON-1 and QGP-1 displayed high expression of genes associated with immature or non-functional β/δ-cells genes (i.e., NEUROG3), or pancreatic endocrine progenitors (i.e., FOXA2). NGS-based identification of miRs in BON-1 and QGP-1 cells revealed the presence of all six members of the miR-17-92 cluster, which have been implicated in b-cell function and differentiation, but also have roles in cancer being both oncogenic or tumor suppressive. Notably, both BON-1 and QGP-1 cells expressed several miRs known to be negatively associated with epithelial-mesenchymal transition, invasion or metastasis. Moreover, both cell lines failed to exhibit migratory activity in vitro. Taken together, NT-3 cells resemble mature functional β-cells, while both BON-1 and QGP-1 are more similar to immature/non-functional pancreatic β/δ-cells or pancreatic endocrine progenitors. Based on the recent identification of three transcriptional subtypes in panNETs, NT-3 cells resemble the "islet/insulinoma tumors" (IT) subtype, while BON-1 and QGP-1 cells were tentatively classified as "metastasis-like/primary" (MLP). Our results provide a comprehensive characterization of three panNET cell lines and demonstrate their relevance as neuroendocrine tumor models.

AB - Experimental models of neuroendocrine tumor disease are scarce, with only a few existing neuroendocrine tumor cell lines of pancreatic origin (panNET). Their molecular characterization has so far focused on the neuroendocrine phenotype and cancer-related mutations, while a transcription-based assessment of their developmental origin and malignant potential is lacking. In this study, we performed immunoblotting and qPCR analysis of neuroendocrine, epithelial, developmental endocrine-related genes as well as next-generation sequencing (NGS) analysis of microRNAs (miRs) on three panNET cell lines, BON-1, QGP-1, and NT-3. All three lines displayed a neuroendocrine and epithelial phenotype; however, while insulinoma-derived NT-3 cells preferentially expressed markers of mature functional pancreatic β-cells (i.e., INS, MAFA), both BON-1 and QGP-1 displayed high expression of genes associated with immature or non-functional β/δ-cells genes (i.e., NEUROG3), or pancreatic endocrine progenitors (i.e., FOXA2). NGS-based identification of miRs in BON-1 and QGP-1 cells revealed the presence of all six members of the miR-17-92 cluster, which have been implicated in b-cell function and differentiation, but also have roles in cancer being both oncogenic or tumor suppressive. Notably, both BON-1 and QGP-1 cells expressed several miRs known to be negatively associated with epithelial-mesenchymal transition, invasion or metastasis. Moreover, both cell lines failed to exhibit migratory activity in vitro. Taken together, NT-3 cells resemble mature functional β-cells, while both BON-1 and QGP-1 are more similar to immature/non-functional pancreatic β/δ-cells or pancreatic endocrine progenitors. Based on the recent identification of three transcriptional subtypes in panNETs, NT-3 cells resemble the "islet/insulinoma tumors" (IT) subtype, while BON-1 and QGP-1 cells were tentatively classified as "metastasis-like/primary" (MLP). Our results provide a comprehensive characterization of three panNET cell lines and demonstrate their relevance as neuroendocrine tumor models.

U2 - 10.3390/cancers12030691

DO - 10.3390/cancers12030691

M3 - SCORING: Journal article

C2 - 32183367

VL - 12

SP - 691

JO - CANCERS

JF - CANCERS

SN - 2072-6694

IS - 3

ER -